|
|
Volumn 347, Issue 22, 2002, Pages 1737-1738
|
|
Behind the research: An oral drug for leishmaniasis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B;
ANTILEISHMANIAL AGENT;
MILTEFOSINE;
ANTIPROTOZOAL AGENT;
DRUG DERIVATIVE;
PHOSPHORYLCHOLINE;
ADULT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG RESEARCH;
DRUG SCREENING;
EYE TOXICITY;
FEMALE;
HUMAN;
INDIA;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REPRODUCTIVE TOXICITY;
SHORT SURVEY;
SPLENOMEGALY;
VISCERAL LEISHMANIASIS;
VOMITING;
NOTE;
ORAL DRUG ADMINISTRATION;
ADMINISTRATION, ORAL;
ANTIPROTOZOAL AGENTS;
CLINICAL TRIALS;
HUMANS;
INDIA;
LEISHMANIASIS, VISCERAL;
PHOSPHORYLCHOLINE;
|
|
EID: 0037191610
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMbtr020156 Document Type: Short Survey |
|
Times cited : (4)
|
|
References (0)
|